Panosome GmbH
PrivateLast Round
Grant
Jun 29, 2024
Total Funding Raised
$3.61M
Momentum Score
25 /100
Company Overview
Panosome GmbH is a biotechnology company developing antibodies for challenging target classes such as carbohydrates, peptides, and small molecules for indications ranging from cancer to autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Panosome GmbH Comps
Public and private peers based on sector, stage, and business model.
Panosome GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 29, 2024 | ||||
| Early Funding | May 21, 2024 | ||||
| Grant | May 21, 2024 |
Panosome GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bundesministerium für Bildung und Forschung | Grant |
| Encourage Ventures | Early Funding |
Panosome GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Panosome GmbH's valuation, stock price, and market status.
